DarioHealth Corp (DRIO)vsHinge Health, Inc. (HNGE)
DRIO
DarioHealth Corp
$6.63
-2.07%
HEALTHCARE · Cap: $67.91M
HNGE
Hinge Health, Inc.
$95.57
+3.90%
HEALTHCARE · Cap: $7.62B
Smart Verdict
WallStSmart Research — data-driven comparison
Hinge Health, Inc. generates 3329% more annual revenue ($720.06M vs $21.00M). HNGE leads profitability with a 15.1% profit margin vs -169.9%. HNGE earns a higher WallStSmart Score of 52/100 (C-).
DRIO
Avoid23
out of 100
Grade: F
HNGE
Buy52
out of 100
Grade: C-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+7.4%
Fair Value
$11.88
Current Price
$6.63
$5.25 discount
Intrinsic value data unavailable for HNGE.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Every $100 of equity generates 101 in profit
Attractively priced relative to earnings
Revenue surging 53.0% year-over-year
Conservative balance sheet, low leverage
Areas to Watch
0.0% earnings growth
Smaller company, higher risk/reward
Weak financial health signals
Revenue declined 3.6%
Weak financial health signals
Trading at 22.3x book value
ROE of -197.2% — below average capital efficiency
Earnings declined 68.4%
Comparative Analysis Report
WallStSmart ResearchBull Case : DRIO
The strongest argument for DRIO centers on Price/Book, Return on Equity.
Bull Case : HNGE
The strongest argument for HNGE centers on P/E Ratio, Revenue Growth, Debt/Equity. Profitability is solid with margins at 15.1% and operating margin at 19.0%. Revenue growth of 53.0% demonstrates continued momentum.
Bear Case : DRIO
The primary concerns for DRIO are EPS Growth, Market Cap, Piotroski F-Score.
Bear Case : HNGE
The primary concerns for HNGE are Piotroski F-Score, Price/Book, Return on Equity.
Key Dynamics to Monitor
DRIO profiles as a turnaround stock while HNGE is a growth play — different risk/reward profiles.
HNGE is growing revenue faster at 53.0% — sustainability is the question.
HNGE generates stronger free cash flow (100M), providing more financial flexibility.
Monitor HEALTH INFORMATION SERVICES industry trends, competitive dynamics, and regulatory changes.
Bottom Line
HNGE scores higher overall (52/100 vs 23/100), backed by strong 15.1% margins and 53.0% revenue growth. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
DarioHealth Corp
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
DarioHealth Corp. The company is headquartered in New York, New York.
Visit Website →Hinge Health, Inc.
HEALTHCARE · HEALTH INFORMATION SERVICES · USA
Hinge Health, Inc. develops health care software for joint and muscle health. The company is headquartered in San Francisco, California.
Visit Website →Compare with Other HEALTH INFORMATION SERVICES Stocks
Want to dig deeper into these stocks?